Literature DB >> 21037093

Chlamydia-specific CD4 T cell clones control Chlamydia muridarum replication in epithelial cells by nitric oxide-dependent and -independent mechanisms.

Krupakar Jayarapu1, Micah Kerr, Susan Ofner, Raymond M Johnson.   

Abstract

Chlamydia trachomatis serovars D-K are sexually transmitted intracellular bacterial pathogens that replicate in epithelial cells lining the human reproductive tract. It is clear from knockout mice and T cell depletion studies using Chlamydia muridarum that MHC class II and CD4 T cells are critical for clearing bacteria from the murine genital tract. It is not clear how CD4 T cells interact with infected epithelial cells to mediate bacterial clearance in vivo. Previous work using an epithelial tumor cell line showed that a Chlamydia-specific CD4 T cell clone was able to inhibit C. muridarum replication in vitro via induction of epithelial NO production. We have previously shown that Chlamydia-specific CD4 T cell clones can recognize and be activated by infected reproductive tract epithelial cells and block Chlamydia replication in them. We extend those observations by investigating the mechanism used by a panel of CD4 T cell clones to control Chlamydia replication in epithelial cells. We found that Chlamydia-specific CD4 T cell clones were cytolytic, but that cytolysis was not likely critical for controlling C. muridarum replication. For one, CD4 T cell clone-induced epithelial NO production was critical for controlling replication; however, the most potent CD4 T cell clones were dependent on T cell degranulation for replication control with only a minor additional contribution from NO production. We discuss our data as they relate to existing knockout mouse studies addressing mechanisms of T cell-mediated control of Chlamydia replication and their implications for intracellular epithelial pathogens in mouse models.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21037093      PMCID: PMC3073083          DOI: 10.4049/jimmunol.1002596

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  Expression of genes encoding Th1 cell-activating cytokines and lymphoid homing chemokines by chlamydia-pulsed dendritic cells correlates with protective immunizing efficacy.

Authors:  J H Shaw; V R Grund; L Durling; H D Caldwell
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

2.  Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome.

Authors:  K H Ramsey; G S Miranpuri; I M Sigar; S Ouellette; G I Byrne
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 3.  Risk of sequelae after Chlamydia trachomatis genital infection in women.

Authors:  Catherine L Haggerty; Sami L Gottlieb; Brandie D Taylor; Nicola Low; Fujie Xu; Roberta B Ness
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

4.  Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells.

Authors:  Christine Roshick; Heidi Wood; Harlan D Caldwell; Grant McClarty
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

5.  Chlamydia muridarum infection elicits a beta interferon response in murine oviduct epithelial cells dependent on interferon regulatory factor 3 and TRIF.

Authors:  Wilbert A Derbigny; Soon-Cheol Hong; Micah S Kerr; M'hamed Temkit; Raymond M Johnson
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

6.  Chlamydia muridarum-specific CD4 T-cell clones recognize infected reproductive tract epithelial cells in an interferon-dependent fashion.

Authors:  Krupakar Jayarapu; Micah S Kerr; Adrian Katschke; Raymond M Johnson
Journal:  Infect Immun       Date:  2009-08-10       Impact factor: 3.441

7.  Chlamydial IFN-gamma immune evasion is linked to host infection tropism.

Authors:  David E Nelson; Dezso P Virok; Heidi Wood; Christine Roshick; Raymond M Johnson; William M Whitmire; Deborah D Crane; Olivia Steele-Mortimer; Laszlo Kari; Grant McClarty; Harlan D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-14       Impact factor: 11.205

8.  The molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide.

Authors:  J U Igietseme
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

9.  Chlamydia muridarum evades growth restriction by the IFN-gamma-inducible host resistance factor Irgb10.

Authors:  Jörn Coers; Isaac Bernstein-Hanley; David Grotsky; Iana Parvanova; Jonathan C Howard; Gregory A Taylor; William F Dietrich; Michael N Starnbach
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

10.  IFN-gamma-inducible Irga6 mediates host resistance against Chlamydia trachomatis via autophagy.

Authors:  Munir A Al-Zeer; Hesham M Al-Younes; Peter R Braun; Jens Zerrahn; Thomas F Meyer
Journal:  PLoS One       Date:  2009-02-26       Impact factor: 3.240

View more
  21 in total

1.  Integrin α4β1 is necessary for CD4+ T cell-mediated protection against genital Chlamydia trachomatis infection.

Authors:  Sergio J Davila; Andrew J Olive; Michael N Starnbach
Journal:  J Immunol       Date:  2014-03-21       Impact factor: 5.422

2.  Modeling the transcriptome of genital tract epithelial cells and macrophages in healthy mucosa versus mucosa inflamed by Chlamydia muridarum infection.

Authors:  Raymond M Johnson; Micah S Kerr
Journal:  Pathog Dis       Date:  2015-10-29       Impact factor: 3.166

Review 3.  Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.

Authors:  Sam Vasilevsky; Gilbert Greub; Denise Nardelli-Haefliger; David Baud
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

4.  PmpG303-311, a protective vaccine epitope that elicits persistent cellular immune responses in Chlamydia muridarum-immune mice.

Authors:  Raymond M Johnson; Hong Yu; Micah S Kerr; James E Slaven; Karuna P Karunakaran; Robert C Brunham
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

Review 5.  Tissue-Resident T Cells as the Central Paradigm of Chlamydia Immunity.

Authors:  Raymond M Johnson; Robert C Brunham
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

6.  Caveolin-mediated endocytosis of the Chlamydia M278 outer membrane peptide encapsulated in poly(lactic acid)-Poly(ethylene glycol) nanoparticles by mouse primary dendritic cells enhances specific immune effectors mediated by MHC class II and CD4+ T cells.

Authors:  Saurabh Dixit; Rajnish Sahu; Richa Verma; Skyla Duncan; Guillermo H Giambartolomei; Shree R Singh; Vida A Dennis
Journal:  Biomaterials       Date:  2017-12-26       Impact factor: 12.479

7.  Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells.

Authors:  Hong Yu; Karuna P Karunakaran; Isabelle Kelly; Caixia Shen; Xiaozhou Jiang; Leonard J Foster; Robert C Brunham
Journal:  J Immunol       Date:  2011-02-04       Impact factor: 5.422

8.  Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice.

Authors:  Hong Yu; Karuna P Karunakaran; Xiaozhou Jiang; Robert C Brunham
Journal:  Vaccine       Date:  2014-06-30       Impact factor: 3.641

9.  An atypical CD8 T-cell response to Chlamydia muridarum genital tract infections includes T cells that produce interleukin-13.

Authors:  Raymond M Johnson; Micah S Kerr; James E Slaven
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

Review 10.  Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis.

Authors:  Hong Yu; Karuna P Karunakaran; Xiaozhou Jiang; Robert C Brunham
Journal:  Expert Rev Vaccines       Date:  2016-03-21       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.